Related Experiment Videos
[Blood component therapy: differential indication for erythrocyte transfusion]
Infusionstherapie Und Klinische Ernahrung
|August 1, 1980
Summary
Red blood cell transfusions are guided by blood loss severity and patient condition. Different preparations like packed red cells and leukocyte-poor concentrates offer varying benefits and risks for transfusion reactions and alloimmunization.
Area of Science:
- Hematology
- Transfusion Medicine
Context:
- Red blood cell (RBC) transfusions are critical in managing anemia and acute blood loss.
- Indications for RBC transfusion vary significantly between acute and chronic anemia.
- Various RBC preparations exist, each with specific clinical applications and risk profiles.
Purpose:
- To outline the general principles and specific indications for red blood cell application.
- To review the advantages and disadvantages of different red blood cell preparations.
- To guide clinical decision-making in red blood cell transfusion therapy.
Summary:
- RBC transfusions are indicated when hemoglobin falls below 10 g/dl or hematocrit below 30% in acute blood loss, and differently in chronic anemia and preoperatively.
- Whole blood is reserved for massive transfusion; packed red cells reduce volume risk and non-hemolytic reactions.
- Leukocyte-poor RBCs and washed RBCs address specific transfusion reactions and alloimmunization risks, while cryopreserved RBCs offer long-term storage with some viral risk reduction.
Impact:
- Optimizing RBC transfusion strategies can improve patient outcomes by minimizing transfusion risks.
- Understanding preparation-specific benefits aids in selecting the most appropriate RBC product.
- Informed use of RBCs supports efficient blood resource management and patient safety.